Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study
Press Releases
Levee Medical  
March 4, 2025

Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study

Multicenter, randomized controlled pivotal study to investigate a novel device for post-radical prostatectomy stress urinary incontinence

logo salamanca press

Salamanca Press

Local & Social